View on Pubmed.gov 11952893 | View on doi.org 10.1046/j.1365-...
A genome-wide strategy for the identification of essential genes in Staphylococcus aureus.
- Elitra Pharmaceuticals, San Diego, CA 92121, USA.
Abstract
To address the need for new approaches to antibiotic drug development, we have identified a large number of essential genes for the bacterial pathogen, Staphylococcus aureus, using a rapid shotgun antisense RNA method. Staphylococcus aureus chromosomal DNA fragments were cloned into a xylose-inducible expression plasmid and transformed into S. aureus. Homology comparisons between 658 S. aureus genes identified in this particular antisense screen and the Mycoplasma genitalium genome, which contains 517 genes in total, yielded 168 conserved genes, many of which appear to be essential in M. genitalium and other bacteria. Examples are presented in which expression of an antisense RNA specifically reduces its cognate mRNA. A cell-based, drug-screening assay is also described, wherein expression of an antisense RNA confers specific sensitivity to compounds targeting that gene product. This approach enables facile assay development for high throughput screening for any essential gene, independent of its biochemical function, thereby greatly facilitating the search for new antibiotics.
References
Cited by 478 citations (total)
Journal Article
Discovery of FabH/FabF inhibitors from natural products.
Electronic publication date March 24, 2006
Katherine Young [...] Jun Wang et al.
Condensing enzymes are essential in type II fatty acid synthesis and are promising targets for antibacterial drug discovery. Recently, a...
Journal Article Research Support, Non-U.S. Gov't Review
Vaccinology in the genome era.
Electronic publication date October 3, 2009
C Daniela Rinaudo [...] Kate L Seib et al.
Vaccination has played a significant role in controlling and eliminating life-threatening infectious diseases throughout the world, and yet currently licensed...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •